MYC and hepatocellular carcinoma: For instance, in thyroid cancer, the miR-545-3p/SLC7A11 cascade [99], in human oral squamous cell carcinoma, the miR-125b-5p/SLC7A11 cascade and miR-34c-3p/SLC7A11 cascade [100,101], in cervical cancer, the circEPSTI1/miR-375, miR-409-3p, miR-515-5p/SLC7A11 cascade [102], in hepatocellular carcinoma (HCC), the circ0097009/miR-1261/SLC7A11 cascade [103], in prostate cancer (PrC), the c-Myc/miR-25-3p/SLC7A11 cascade [104], and in renal cell carcinoma, the lncRNA SLC16A1-AS1/miR-143-3p/SLC7A11 cascade [105], all involve miRNAs targeting SLC7A11.